News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
531,245 Results
Type
Article (33829)
Company Profile (183)
Press Release (497233)
Section
Business (155370)
Career Advice (874)
Deals (25321)
Drug Delivery (62)
Drug Development (59617)
Employer Resources (87)
FDA (14229)
Job Trends (11932)
News (260130)
Policy (24179)
Tag
Academia (2298)
Alliances (43306)
Alzheimer's disease (910)
Approvals (14177)
Artificial intelligence (131)
Bankruptcy (204)
Best Places to Work (9686)
Biotechnology (135)
Breast cancer (97)
Cancer (821)
Cardiovascular disease (72)
Career advice (773)
Cell therapy (183)
Clinical research (47643)
Collaboration (333)
Compensation (83)
COVID-19 (1953)
C-suite (81)
Data (848)
Diabetes (115)
Diagnostics (5612)
Earnings (53628)
Employer resources (78)
Events (75296)
Executive appointments (234)
FDA (14668)
Funding (258)
Gene therapy (126)
GLP-1 (415)
Government (3433)
Healthcare (15539)
Infectious disease (2017)
Inflammatory bowel disease (82)
Interviews (110)
IPO (10847)
Job creations (2581)
Job search strategy (679)
Layoffs (226)
Legal (4939)
Lung cancer (137)
Manufacturing (117)
Medical device (13829)
Medtech (13834)
Mergers & acquisitions (14546)
Metabolic disorders (300)
Neuroscience (1097)
NextGen Class of 2024 (5430)
Non-profit (3462)
Northern California (1016)
Obesity (164)
Opinion (115)
Patents (82)
People (46888)
Phase I (14705)
Phase II (20828)
Phase III (16087)
Pipeline (285)
Postmarket research (1805)
Preclinical (5767)
Radiopharmaceuticals (204)
Rare diseases (144)
Real estate (4632)
Regulatory (16805)
Research institute (2091)
Resumes & cover letters (135)
Southern California (912)
Startups (3211)
United States (9815)
Vaccines (421)
Weight loss (122)
Date
Today (177)
Last 7 days (767)
Last 30 days (2751)
Last 365 days (28016)
2024 (25025)
2023 (31987)
2022 (42421)
2021 (45900)
2020 (44742)
2019 (39314)
2018 (29958)
2017 (26893)
2016 (25855)
2015 (30142)
2014 (22891)
2013 (19279)
2012 (20849)
2011 (21337)
2010 (19678)
Location
Africa (529)
Arizona (141)
Asia (33197)
Australia (5638)
California (2280)
Canada (1014)
China (199)
Colorado (106)
Connecticut (118)
Europe (70210)
Florida (359)
Georgia (96)
Illinois (267)
Indiana (153)
Kansas (94)
Maryland (495)
Massachusetts (1680)
Michigan (156)
Minnesota (216)
New Jersey (731)
New York (691)
North Carolina (559)
Northern California (1016)
Ohio (115)
Pennsylvania (579)
South America (789)
Southern California (912)
Texas (332)
Utah (74)
Washington State (280)
531,245 Results for "creative medical technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin
Creative Medical Technology Holdings, Inc. announced that it has successfully generated human induced pluripotent stem cells -derived Islet Cells that produce human insulin.
June 24, 2024
·
3 min read
Press Releases
Creative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
October 24, 2024
·
3 min read
Policy
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
Creative Medical Technology Holdings, Inc. is pleased to announce the successful receipt of Orphan Drug Designation from the U.S. Food and Drug Administration for CELZ-101, ImmCelzTM.
March 6, 2024
·
4 min read
Creative Biolabs: The Antibody Landscape Is Revolving
As the industry witnesses a surge in demand for innovative antibodies on prevalent research targets, Creative Biolabs is poised to meet and exceed these expectations with their comprehensive suite of services.
June 5, 2024
·
3 min read
Creative Enzymes Introduces Fermented Calcium Propionate for Superior Food Preservation Solutions
In an exciting development for the food industry, Creative Enzymes has introduced Fermented Calcium Propionate, a cutting-edge ingredient poised to revolutionize food preservation methods.
June 21, 2024
·
2 min read
Press Releases
Creative Enzymes Launches Innovative Enzymatic Solutions for Sustainable Leather Processing
November 1, 2024
·
1 min read
BioMidwest
Creative Medical Technology Holdings Provides Corporate Update
Creative Medical Technology Holdings, Inc., a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, provided an update on recent business activities.
June 12, 2023
·
6 min read
Drug Development
Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™.
December 20, 2023
·
3 min read
Creative Proteomics Introduces Advanced GST Pull-Down Service for Protein Interaction Studies
Creative Proteomics, a renowned leader in proteomics services, is making waves in the field of protein interaction studies with its cutting-edge GST Pull-Down Service.
May 24, 2024
·
3 min read
Press Releases
Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program
July 25, 2024
·
3 min read
1 of 53,125
Next
